Randomized Phase III Study of Oxaliplatin, Fluorouracil and Leucovorin (FOLFOX) With or Without Regorafenib in Patients With Metastatic Colorectal Cancer Progressed After First-line Irinotecan Plus Fluoropyrimidines
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fluorouracil; Folinic acid; Oxaliplatin; Regorafenib
- Indications Colorectal cancer
- Focus Therapeutic Use
- 13 Mar 2013 Biomarkers information updated
- 12 Mar 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 13 Feb 2013 New trial record